Literature DB >> 17117075

Positive correlation between standardized uptake values of FDG uptake in the stomach and the value of the C-13 urea breath test.

Chun-Yi Lin1, Chiu-Shoung Liu, Hueisch-Jy Ding, Shung-Shung Sun, Kuo-Yang Yen, Te-Chun Hsieh, Cheng-Chieh Lin, Chia-Hung Kao.   

Abstract

PURPOSE: The distribution of FDG uptake in the stomach is variable. Gastritis is one of the causes of elevated FDG uptake. Helicobacter pylori (HP) infection was found in approximately 80% of patients with peptic ulcer and 30% to 60% of symptomatic gastritis. The C-13 urea breath test (UBT) is one of the gold standard tools in diagnosis of HP infection. The aim of this study was to assess the correlation between standardized uptake values (SUVs) of FDG uptake in the stomach and the value of the C-13 urea breath test (UBT).
METHODS: Sixteen patients, referred from the department of community medicine, for FDG PET for health examination were chronologically enrolled for detection of HP infection by using the C-13 UBT within 1 week. The maximal SUVs of FDG uptake in the gastric wall as well as the value of the C-13 UBT were measured. The correlation between maximal SUVs of FDG uptake in the stomach and the value of the C-13 UBT was observed.
RESULTS: We took the results of C-13 UBT as the final diagnosis of HP infection. Of 16 patients, 5 were HP-infected and 11 were uninfected. Standardized uptake values of FDG uptake in the gastric wall were strong positively correlated with the value of the C-13 UBT in this retrospective study (P < 0.001).
CONCLUSION: Except for gastric cancer, HP infection has to be concerned when high SUVs of FDG uptake in the stomach are noted.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17117075     DOI: 10.1097/01.rlu.0000247742.52969.6b

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  6 in total

1.  Significance of SUV on Follow-up F-18 FDG PET at the Anastomotic Site of Gastroduodenostomy after Distal Subtotal Gastrectomy in Patients with Gastric Cancer.

Authors:  Byung Wook Choi; Seok Kil Zeon; Sung Hun Kim; Il Jo; Hae Won Kim; Kyoung Sook Won
Journal:  Nucl Med Mol Imaging       Date:  2011-09-09

2.  Prognostic value and clinical correlations of 18-fluorodeoxyglucose metabolism quantifiers in gastric cancer.

Authors:  Kinga Grabinska; Maciej Pelak; Jerzy Wydmanski; Andrzej Tukiendorf; Andrea d'Amico
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

3.  Assessment of (18)F-fluorodeoxyglucose positron emission tomography combined with computed tomography in the preoperative management of patients with gastric cancer.

Authors:  Tsutomu Namikawa; Takehiro Okabayshi; Munenobu Nogami; Yasuhiro Ogawa; Michiya Kobayashi; Kazuhiro Hanazaki
Journal:  Int J Clin Oncol       Date:  2013-07-24       Impact factor: 3.402

4.  13C-urea breath test values and Helicobacter pylori eradication.

Authors:  Angelo Zullo; Federico Perna; Chiara Ricci; Cesare Hassan; Andrea Tampieri; Vincenzo De Francesco; Sergio Morini; Dino Vaira
Journal:  Dig Dis Sci       Date:  2007-06-28       Impact factor: 3.199

Review 5.  PET/CT for Predicting Occult Lymph Node Metastasis in Gastric Cancer.

Authors:  Danyu Ma; Ying Zhang; Xiaoliang Shao; Chen Wu; Jun Wu
Journal:  Curr Oncol       Date:  2022-09-11       Impact factor: 3.109

6.  18F-FDG uptake in the stomach on screening PET/CT: value for predicting Helicobacter pylori infection and chronic atrophic gastritis.

Authors:  Shigeki Kobayashi; Mayumi Ogura; Naohisa Suzawa; Noriyuki Horiki; Masaki Katsurahara; Toru Ogura; Hajime Sakuma
Journal:  BMC Med Imaging       Date:  2016-10-18       Impact factor: 1.930

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.